Home LiteratureArticle Details
PMID: 8738607 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.

Breast cancer research and treatment ·Vol. 39 ·No. 1 ·1996-00-00 ·Pages 69-86

Clarke R

Abstract

The ability to maintain and study human tissues in an in vivo environment has proved to be a valuable tool in breast cancer research for several decades. The most widely studied tissues have been xenografts of established human breast cancer cell lines into athymic nude mice. Human breast tumor xenografts provide the opportunity to study various important interactions between the tumor and host tissues, including endocrinologic, immunologic, and tumor-stroma interactions. The nude mouse is not the only immune-deficient recipient system in which to study xenografts. Additional single and combined mutant strains have been used successfully, including mice homozygous for the severe combined immune deficiency mutation (scid), both the beige (bg) and nude (nu) mutations in combination (bg/nu), and mice bearing the combined bg/nu/xid mutations. The differing immunobiologies are discussed, with particular reference to the immunobiology of breast cancer, as are the characteristics of several of the more frequently utilized breast cancer xenografts and cell lines. The ability of several endocrine treatments to modulate effectors of cell mediated immunity, e.g., estrogens and antiestrogens, and the effect of site of inoculation on tumor take and metastasis, also are described.

MeSH Terms
Animals Breast Neoplasms/immunology Disease Models, Animal Drug Resistance Female Gonadal Steroid Hormones/pharmacology Humans Immunity, Cellular Immunologic Surveillance/immunology Mice Mice, Nude Mice, SCID Mutation/genetics Neoplasm Transplantation Transplantation, Heterologous Tumor Cells, Cultured
Chemicals
Gonadal Steroid Hormones
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Clarke R
Vincent T. Lombardi Cancer Center, Georgetown University Medical School, Washington, DC, USA.
References (133)
133 references, click to expand
  1. Abrogation of hematogenous metastases in a murine model by natural killer cells.
    Surgery. 1984 Aug;96(2):133-8 PMID: 6463854
  2. Immunophenotype of the lymphoid cell infiltrates in breast carcinomas of low oestrogen receptor content.
    Br J Cancer. 1987 Dec;56(6):744-6 PMID: 3435700
  3. Peyer's patches, gut IgA plasma cells and thymic function: study in nude mice bearing thymic grafts.
    J Immunol. 1975 Aug;115(2):361-4 PMID: 807633
  4. Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell loss.
    Eur J Cancer. 1994;30A(10):1559-64 PMID: 7833119
  5. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.
    Mol Endocrinol. 1987 Mar;1(3):216-23 PMID: 3502607
  6. The inception of the response to SRBC by nude mice injected with various doses of congenic or allogeneic thymus cells.
    Cell Immunol. 1975 May;17(1):277-84 PMID: 1092475
  7. Immunologic responsiveness of the breast cancer patient.
    Cancer. 1980 Aug 15;46(4 Suppl):893-8 PMID: 7397664
  8. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.
    Cancer Res. 1990 Mar 15;50(6):1748-56 PMID: 1968358
  9. Influence of tumor transplantation methods on tumor growth rate and metastatic potential of solitary tumors derived from metastases.
    Clin Exp Metastasis. 1990 Jul-Aug;8(4):381-9 PMID: 2350921
  10. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice.
    Cancer Res. 1983 May;43(5):2223-39 PMID: 6831445
  11. Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro.
    Cancer Res. 1989 Sep 1;49(17):4765-9 PMID: 2758410
  12. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo.
    Mol Endocrinol. 1988 Oct;2(10):886-92 PMID: 3185565
  13. Effect of thymus cell injections on germinal center formation in lymphoid tissues of nude (thymusless) mice.
    Cell Immunol. 1974 Sep;13(3):416-30 PMID: 4217657
  14. Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.
    Am J Pathol. 1985 Sep;120(3):464-77 PMID: 2412448
  15. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas.
    Cancer Res. 1978 Oct;38(10):3352-64 PMID: 688225
  16. Influence of implantation site on formation of metastases.
    Cancer Metastasis Rev. 1983;2(3):295-306 PMID: 6367968
  17. Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects.
    Cancer Res. 1984 Oct;44(10):4403-8 PMID: 6467201
  18. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
    Endocrinology. 1985 Oct;117(4):1409-17 PMID: 4029083
  19. Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells.
    Int J Cancer. 1977 Apr 15;19(4):555-64 PMID: 844921
  20. Influence of sera from patients affected by neoplasia on some human macrophage functions.
    Cancer Detect Prev. 1988;12(1-6):73-80 PMID: 2846174
  21. Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism.
    Nature. 1977 Sep 22;269(5626):338-40 PMID: 198666
  22. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency.
    Cell. 1986 Sep 26;46(7):963-72 PMID: 3093081
  23. Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self.
    Biochim Biophys Acta. 1988 Nov 15;948(2):151-73 PMID: 3052591
  24. Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.
    Proc Natl Acad Sci U S A. 1989 May;86(10):3649-53 PMID: 2726742
  25. Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice.
    J Immunol. 1985 Nov;135(5):2911-3 PMID: 3876368
  26. Eradication of cancer metastasis by tumoricidal macrophages.
    Adv Exp Med Biol. 1988;233:415-23 PMID: 3223395
  27. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines.
    J Natl Cancer Inst. 1989 May 10;81(10):781-8 PMID: 2523976
  28. The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function.
    J Immunol. 1979 Nov;123(5):2168-73 PMID: 489978
  29. Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis.
    Breast Cancer Res Treat. 1996;39(1):103-17 PMID: 8738610
  30. Comparative abilities of athymic nude mice and severe combined immune deficient (SCID) mice to accept transplants of induced rat mammary carcinomas: enhanced transplantation efficiency of those rat mammary carcinomas that have elevated expression of neu oncogene.
    Int J Cancer. 1993 Apr 1;53(6):1002-7 PMID: 8097186
  31. The response to chemotherapy of a variety of human tumour xenografts.
    Br J Cancer. 1983 Jan;47(1):1-13 PMID: 6336942
  32. Growth of human tumor xenografts in nude mice and mice with severe combined immunodeficiency (SCID).
    Surg Today. 1993;23(4):375-7 PMID: 8391349
  33. The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer.
    J Endocrinol. 1989 Jul;122(1):331-40 PMID: 2769157
  34. MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer.
    Br J Cancer. 1996 Jan;73(2):154-61 PMID: 8546900
  35. Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity.
    Breast Cancer Res Treat. 1986;7(3):187-92 PMID: 3779116
  36. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
    Cancer Res. 1994 Feb 1;54(3):825-31 PMID: 7905787
  37. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines.
    J Clin Invest. 1989 Mar;83(3):921-6 PMID: 2646321
  38. Host defense mechanisms against murine cytomegalovirus infection induced by poly I:C in severe combined immune deficient (SCID) mice.
    Proc Soc Exp Biol Med. 1994 Nov;207(2):191-6 PMID: 7524103
  39. Macrophages in human breast disease: a quantitative immunohistochemical study.
    Br J Cancer. 1988 Feb;57(2):174-7 PMID: 2833921
  40. Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration.
    Cancer Res. 1988 Sep 15;48(18):5183-7 PMID: 3409244
  41. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
    Cancer Res. 1993 May 1;53(9):2168-77 PMID: 8481920
  42. Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture.
    J Biol Chem. 1981 Jul 10;256(13):6895-902 PMID: 7240250
  43. Macrophages and cancer.
    Cancer Metastasis Rev. 1990 Feb;8(4):319-51 PMID: 2182211
  44. Immunoglobulin isotypes in plasma cells of normal and athymic mice.
    Cell Immunol. 1979 May;44(2):343-51 PMID: 455477
  45. Tumorigenicity and dissemination of human tumors in congenitally immune-deficient mice.
    J Natl Cancer Inst. 1991 Oct 2;83(19):1419-20 PMID: 1920486
  46. Establishment and characterization of a cell line of human breast carcinoma origin.
    Eur J Cancer. 1979 May;15(5):659-70 PMID: 228940
  47. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients.
    Psychosom Med. 1990 Jan-Feb;52(1):73-85 PMID: 2305024
  48. Granulosa cell tumorigenesis in genetically hypogonadal-immunodeficient mice grafted with ovaries from tumor-susceptible donors.
    Cancer Res. 1993 Aug 15;53(16):3741-6 PMID: 8339285
  49. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
    J Immunol. 1985 Jun;134(6):3798-801 PMID: 3989296
  50. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice.
    Cancer Res. 1990 Feb 1;50(3):717-21 PMID: 2297709
  51. Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours.
    Int J Cancer. 1979 Nov 15;24(5):579-85 PMID: 160895
  52. Studies on beige-nude mice with low natural killer cell activity. 1. Introduction of the bg gene into nude mice and the characteristics of beige-nude mice.
    Lab Anim. 1987 Jan;21(1):72-7 PMID: 3560866
  53. The scid factor on human chromosome 8 restores V(D)J recombination in addition to double-strand break repair.
    Cancer Res. 1995 Apr 15;55(8):1774-9 PMID: 7712487
  54. Role of NK cells in the control of metastatic spread and growth of tumor cells in mice.
    Int J Cancer. 1982 Jul 15;30(1):107-12 PMID: 7118294
  55. Tamoxifen withdrawal response. Report of a case.
    Arch Intern Med. 1989 Feb;149(2):449-50 PMID: 2537066
  56. Serum steroid levels in intact and endocrine ablated BALB/c nude mice and their intact littermates.
    J Steroid Biochem. 1986 Sep;25(3):429-32 PMID: 2945970
  57. A human cell line from a pleural effusion derived from a breast carcinoma.
    J Natl Cancer Inst. 1973 Nov;51(5):1409-16 PMID: 4357757
  58. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    J Exp Med. 1982 Jun 1;155(6):1823-41 PMID: 6176669
  59. Interleukin-2 induces cytotoxic activity in lymphocytes from regional axillary nodes of breast cancer patients.
    Cancer. 1988 Feb 15;61(4):629-34 PMID: 3257405
  60. [Possible cytotoxic mechanisms of TNF in vitro].
    Hum Cell. 1990 Jun;3(2):107-12 PMID: 1964798
  61. Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.
    Int J Cancer. 1980 May 15;25(5):573-82 PMID: 6154662
  62. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance.
    Cancer Res. 1989 Jul 15;49(14):3844-8 PMID: 2544260
  63. Dietary fat and breast cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study.
    J Natl Cancer Inst. 1987 Sep;79(3):465-71 PMID: 3476789
  64. Metastatic behavior of human tumor cell lines grown in the nude mouse.
    Cancer Res. 1984 Aug;44(8):3522-9 PMID: 6744277
  65. Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice.
    Cancer Res. 1993 Oct 1;53(19):4686-90 PMID: 8402646
  66. Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype.
    Br J Cancer. 1989 Apr;59(4):522-6 PMID: 2713239
  67. A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse.
    Science. 1986 Dec 12;234(4782):1366-71 PMID: 3024317
  68. In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters.
    Am J Pathol. 1987 Jul;128(1):52-60 PMID: 3496796
  69. N:NIH(S)-nu/nu mice with combined immunodeficiency: a new model for human tumor heterotransplantation.
    J Natl Cancer Inst. 1980 Aug;65(2):421-30 PMID: 6967528
  70. Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors.
    Int J Cancer. 1984 Jan 15;33(1):95-105 PMID: 6607223
  71. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel.
    J Natl Cancer Inst. 1991 Jun 5;83(11):769-74 PMID: 1789823
  72. lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis.
    Eur J Cancer. 1992;28A(12):1989-95 PMID: 1384607
  73. The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells.
    Clin Exp Metastasis. 1993 Jan;11(1):15-26 PMID: 8380760
  74. Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect.
    J Exp Med. 1979 Apr 1;149(4):993-8 PMID: 311819
  75. B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens.
    J Exp Med. 1977 Jan 1;145(1):101-10 PMID: 299767
  76. Defective colony formation by B lymphocytes from CBA/N and C3H/HeJ mice.
    J Exp Med. 1977 Feb 1;145(2):249-63 PMID: 299879
  77. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice.
    Cancer Res. 1988 Dec 1;48(23):6863-71 PMID: 2846163
  78. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.
    J Biol Chem. 1986 Nov 25;261(33):15544-9 PMID: 3782078
  79. Transfection of activated c-H-rasEJ/pSV2neo or pSV2neo genes into rat mammary cells: rapid stimulation of clonal diversification of spontaneous metastatic and cell-surface properties.
    Oncogene. 1992 Jun;7(6):1127-35 PMID: 1594244
  80. Macrophage function in germ-free, athymic (nu/nu), and conventional-flora (nu/+) mice.
    J Reticuloendothel Soc. 1980 Jul;28(1):55-66 PMID: 6771397
  81. MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.
    Cancer Res. 1993 Jul 15;53(14):3229-32 PMID: 8324732
  82. Characterization and frequency distribution of lymphoreticular infiltrates in axillary lymph node metastases of invasive ductal carcinoma of the breast.
    Cancer. 1987 Dec 15;60(12):3001-7 PMID: 2824022
  83. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    J Immunol. 1983 Feb;130(2):974-80 PMID: 6848604
  84. Biology of disease. Endogenous control of the neoplastic process.
    Lab Invest. 1983 Feb;48(2):120-39 PMID: 6337299
  85. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice.
    J Natl Cancer Inst. 1981 Jul;67(1):51-6 PMID: 6265682
  86. The cellular basis of immunological recovery in nude mice after thymus grafting.
    Immunology. 1974 Apr;26(4):769-76 PMID: 4153106
  87. Selective immunosuppressive action of a factor produced by colon cancer cells.
    Cancer Res. 1990 Oct 1;50(19):6158-61 PMID: 1698119
  88. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.
    Proc Natl Acad Sci U S A. 1990 Sep;87(17):6698-702 PMID: 2168554
  89. The beige mutation in the mouse selectively impairs natural killer cell function.
    Nature. 1979 Mar 29;278(5703):451-3 PMID: 313007
  90. Animal modeling of human breast tumors: limitations in the use of estrogen pellet implants.
    Breast Cancer Res Treat. 1988 Apr;11(1):77-8 PMID: 3382766
  91. Potential of the scid mouse as a host for human tumors.
    Cancer Metastasis Rev. 1991 Oct;10(3):193-200 PMID: 1764764
  92. Estrogen induced growth of human breast cancer cells (MCF-7) in athymic nude mice is enhanced by secretions from a transplantable pituitary tumor.
    Cancer Lett. 1981 Dec;14(3):309-16 PMID: 7332907
  93. Early arrest of B cell development in nude, X-linked immune-deficient mice.
    Eur J Immunol. 1986 Sep;16(9):1125-30 PMID: 3093247
  94. Clinical significance of tamoxifen withdrawal response.
    Lancet. 1987 Jan 3;1(8523):36 PMID: 2879105
  95. The SCID mouse mutant: definition, characterization, and potential uses.
    Annu Rev Immunol. 1991;9:323-50 PMID: 1910681
  96. Mutations in mice that influence natural killer (NK) cell activity.
    Immunogenetics. 1981 Mar 1;12(5-6):601-13 PMID: 6971254
  97. Role of NK cells in tumour growth and metastasis in beige mice.
    Nature. 1980 Apr 17;284(5757):622-4 PMID: 7366733
  98. Effector and precursor phenotypes of lymphokine-activated killer cells in mice with severe combined immunodeficiency (scid) and athymic (nude) mice.
    Cell Immunol. 1989 Apr 15;120(1):230-9 PMID: 2784720
  99. Heterotransplantation of a human malignant tumour to "Nude" mice.
    Acta Pathol Microbiol Scand. 1969;77(4):758-60 PMID: 5383844
  100. In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL background.
    Int J Cancer. 1980 Dec 15;26(6):789-97 PMID: 7216547
  101. Response of metastatic breast cancer to tamoxifen withdrawal: report of a case.
    J Surg Oncol. 1983 Jan;22(1):45-6 PMID: 6823117
  102. beta-Estradiol reduces natural killer cells in mice.
    J Immunol. 1978 Dec;121(6):2193-8 PMID: 722074
  103. Skin window reactivity to autologous breast cancer. An index of prognostically significant cell-mediated immunity.
    Cancer. 1988 Jul 1;62(1):72-83 PMID: 3383122
  104. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ.
    Cancer Res. 1993 May 1;53(9):2178-87 PMID: 8481921
  105. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.
    J Immunol. 1984 Apr;132(4):1804-8 PMID: 6607948
  106. Strain-dependent growth of a human carcinoma in nude mice with different genetic backgrounds: selection of nude mouse strains useful for anticancer agent screening system.
    Exp Cell Biol. 1982;50(2):115-9 PMID: 7075856
  107. Human breast cancer in the athymic nude mouse: cytostatic effects of long-term antiestrogen therapy.
    Eur J Cancer Clin Oncol. 1987 Aug;23(8):1189-96 PMID: 3653212
  108. Prolactin measurements in normal and hypogonadal (hpg) mice: developmental and experimental studies.
    Endocrinology. 1983 Aug;113(2):545-8 PMID: 6409586
  109. Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes.
    Cell Immunol. 1987 May;106(2):191-202 PMID: 2882860
  110. Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice.
    Int J Cancer. 1989 Nov 15;44(5):892-7 PMID: 2583868
  111. Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7).
    Biochem Biophys Res Commun. 1979 Oct 29;90(4):1328-34 PMID: 518601
  112. Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice.
    Nature. 1980 Apr 17;284(5757):624-6 PMID: 7366734
  113. Comparative studies between nude and scid mice on the growth and metastatic behavior of xenografted human tumors.
    Clin Exp Metastasis. 1992 May;10(3):201-10 PMID: 1582090
  114. Absence of thymus in a mouse mutant.
    Nature. 1968 Jan 27;217(5126):370-1 PMID: 5639157
  115. Assessment of host immune response in breast cancer patients.
    Cancer Detect Prev. 1986;9(3-4):311-7 PMID: 3488806
  116. Macrophage activation and innate resistance to infection in SCID mice.
    Immunobiology. 1994 Oct;191(4-5):424-31 PMID: 7713556
  117. Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression.
    Breast Cancer Res Treat. 1994;31(2-3):237-48 PMID: 7881102
  118. A severe combined immunodeficiency mutation in the mouse.
    Nature. 1983 Feb 10;301(5900):527-30 PMID: 6823332
  119. Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells.
    J Biol Chem. 1981 May 25;256(10):5016-21 PMID: 7228867
  120. Epidermal growth factor receptor status of histological sub-types of breast cancer.
    Br J Cancer. 1988 Oct;58(4):458-60 PMID: 3207600
  121. Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions.
    Crit Rev Oncol Hematol. 1992 Jan;12(1):1-23 PMID: 1540336
  122. Doxorubicin resistance conferred by selective enhancement of intracellular glutathione peroxidase or superoxide dismutase content in human MCF-7 breast cancer cells.
    Free Radic Res Commun. 1991;12-13 Pt 2:779-81 PMID: 2060850
  123. The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism.
    Cell. 1988 Aug 12;54(4):453-60 PMID: 3135938
  124. The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity.
    Adv Immunol. 1982;33:1-71 PMID: 6215838
  125. Immunological changes in human breast cancer.
    Eur J Gynaecol Oncol. 1988;9(6):502-14 PMID: 3234427
  126. Mechanisms of macrophage-mediated tumor cytolysis.
    Adv Exp Med Biol. 1982;146:265-314 PMID: 7102462
  127. Infiltration of interleukin-2-inducible killer cells in ascitic fluid and pleural effusions of advanced cancer patients.
    Cancer Res. 1988 Nov 15;48(22):6321-7 PMID: 2972357
  128. Control of carcinogenesis: a possible role for the activated macrophage.
    Science. 1972 Sep 15;177(4053):998-1000 PMID: 5055947
  129. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
    J Cell Physiol. 1992 Mar;150(3):534-44 PMID: 1537883
  130. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.
    Eur J Immunol. 1975 Feb;5(2):112-7 PMID: 1234049
  131. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.
    Cancer Res. 1993 Jan 15;53(2):283-90 PMID: 8380254
  132. Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminoglutethimide.
    Cancer Immunol Immunother. 1987;24(1):72-5 PMID: 3815420
  133. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.
    Lancet. 1987 Jun 20;1(8547):1398-402 PMID: 2884496
Article Info
Journal
Breast cancer research and treatment
Abbr.
Breast Cancer Res Treat
ISSN
0167-6806
Published
1996-00-00
Pages
69-86
Language
English
Region
Netherlands
NLM ID
8111104
Subset
IM
Grants
NCI NIH HHS · P30-CA51008 · United States
NCI NIH HHS · P50-CA58185 · United States
NCI NIH HHS · R01-CA58022 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com